Abstract
Background and aims
Aging is a complex and multifactorial process that is stimulated by a number of factors including genes and life-style. It is thought that the production of reactive oxygen species (ROS) in the face of antioxidant enzymes and molecules is related to aging and age-related diseases. NAD(P)H oxidase system is the predominant cellular source of ROS, and p22phox, the major component of that system, is essential for the activation of NAD(P)H oxidase. The aim of this study was to investigate the association between p22phox C242T single nucleotide polymorphism and aging in Turkish population.
Methods
Blood samples were collected from 332 volunteers between 18 and 95 years of age and were classified into three groups according to their ages as <65, 65–84 and ≥85. p22phox C242T polymorphism was genotyped by PCR–RFLP method.
Results
CC genotype frequency in the C242T polymorphism is higher in older group (≥85) than younger groups (<65 and 65–85), whereas CT + TT genotype frequency is lower in older group. When the p22phox C242T polymorphism was compared with the mean ages and age groups, statistically significant associations were found.
Conclusions
We showed for the first time that human aging is significantly associated with p22phox C242T genotypes in Turkish population, being highest in CC, intermediate in CT, and lowest in TT homozygote. It is plausible to suggest that CC genotype might protect people from chronic inflammation, diseases as well as from oxidative stress and, thus, individuals with CC genotype might be more advantageous for aging as compared to those with CT + TT genotypes.
Similar content being viewed by others
References
Kregel KC, Zhang HJ (2007) An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 292:18–36
Kayaaltı Z, Sahiner L, Durakoğlugil ME, Söylemezoğlu T (2011) Distributions of interleukin-6 (IL-6) promoter and metallothionein 2A (MT2A) core promoter region gene polymorphisms and their associations with aging in Turkish population. Arch Gerontol Geriatr 53:354–358
Perls T, Terry D (2003) Understanding the determinants of exceptional longevity. Ann Intern Med 139:445–449
Seals DR, Jablonski KL, Donato AJ (2011) Aging and vascular endothelial function in humans. Clin Sci (Lond) 120:357–375
Bokov A, Chaudhuri A, Richardson A (2004) The role of oxidative damage and stress in aging. Mech Ageing Dev 125:811–826
Oliveira BF, Nogueira-Machado JA, Chaves MM (2010) The role of oxidative stress in the aging process. Sci World J 10:1121–1128
Larsen PL (1993) Aging and resistance to oxidative damage in Caenorhabditis elegans. Proc Natl Acad Sci 90:8905–8909
Migliaccio E, Giorgio M, Mele S et al (1999) The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402:309–313
Woods JA, Wilund KR, Martin SA, Kistler BM (2012) Exercise, inflammation and aging. Aging Dis 3:130–140
Zalba G, San José G, Moreno MU, Fortuño A, Díez J (2005) NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension. Antioxid Redox Signal 7:1327–1336
Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK (1996) p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271:23317–23321
Rada B, Leto TL (2008) Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib Microbiol 15:164–187
Fry RC, Begley TJ, Samson LD (2005) Genome-wide responses to DNA-damaging agents. Annu Rev Microbiol 59:357–377
San José G, Fortuño A, Beloqui O, Díez J, Zalba G (2008) NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci 114:173–182
Soccio M, Toniato E, Evangelista V, Carluccio M, De Caterina R (2005) Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur J Clin Invest 35:305–314
Roos D, van Bruggen R, Meischl C (2003) Oxidative killing of microbes by neutrophils. Microbes Infect 5:1307–1315
de Oliveira-Junior EB, Bustamante J, Newburger PE, Condino-Neto A (2011) The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes. Scand J Immunol 73:420–427
Moreno MU, San José G, Fortuño A, Beloqui O, Díez J, Zalba G (2006) The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. J Hypertens 24:1299–1306
Kim KI, Na JE, Kang SY et al (2007) Impact of NAD(P)H oxidase p22 phox gene polymorphism on vascular aging in Korean centenarian and nonagenarian. Int J Cardiol 123:18–22
Fan M, Raitakari OT, Kähönen M et al (2007) CYBA C242T gene polymorphism and flow-mediated vasodilation in a population of young adults: the Cardiovascular Risk in Young Finns. Study J Hypertens 25:1381–1387
Cai H, Duarte N, Wilcken DE, Wang XL (1999) NADH/NADPH oxidase p22 phox C242T polymorphism and coronary artery disease in the Australian population. Eur J Clin Invest 29:744–748
Genius J, Grau AJ, Lichy C (2008) The C242T polymorphism of the NAD(P)H oxidase p22phox subunit is associated with an enhanced risk for cerebrovascular disease at a young age. Cerebrovasc Dis 26:430–433
Perianayagam MC, Liangos O, Kolyada AY et al (2007) NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 18:255–263
Park JY, Ferrell RE, Park JJ et al (2005) NADPH oxidase p22phox gene variants are associated with systemic oxidative stress biomarker responses to exercise training. J Appl Physiol 99:1905–1911
Papaiahgari S, Kleeberger SR, Cho HY, Kalvakolanu DV, Reddy SP (2004) NADPH oxidase and ERK signaling regulates hyperoxia-induced Nrf2-ARE transcriptional response in pulmonary epithelial cells. J Biol Chem 279:42302–42312
Wyche KE, Wang SS, Griendling KK et al (2004) C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 43:1246–1251
Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M (1998) Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97:135–137
Yokoyama M, Inoue N, Kawashima S (2000) Role of the vascular NADH/NADPH oxidase system in atherosclerosis. Ann N Y Acad Sci 902:241–248
Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ (2000) A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 86:391–395
Li A, Prasad A, Mincemoyer R et al (1999) Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. Am J Med Genet 86:57–61
Stanger O, Renner W, Khoschsorur G, Rigler B, Wascher TC (2001) NADH/NADPH oxidase p22 phox C242T polymorphism and lipid peroxidation in coronary artery disease. Clin Physiol 21:718–722
Acknowledgments
This study is partly supported by The Scientific and Technical Research Council of Turkey (TUBITAK; Project No: 109S248, 2010).
Conflict of Interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kayaaltı, Z., Kaya, D., Bacaksız, A. et al. An association between polymorphism of the NADH/NADPH oxidase p22phox (phagocyte oxidase) subunit and aging in Turkish population. Aging Clin Exp Res 25, 511–516 (2013). https://doi.org/10.1007/s40520-013-0129-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-013-0129-3